EWZ NEWS! 47.39 Brazil Index MSCI Ishares (EWZ)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Brazil Index MSCI Ishares (EWZ) 47.39 $EWZ

Uptrend Call Working As iShares MSCI Brazil Index Fund Stock Rises 14.8% (EWZ)
Comtex SmarTrend(R) - Thu Apr 10, 9:55AM CDT
SmarTrend identified an Uptrend for iShares MSCI Brazil Index Fund (NYSE:EWZ) on February 27th, 2014 at $41.17. In approximately 1 month, iShares MSCI Brazil Index Fund has returned 14.81% as of today's recent price of $47.26.

Should You Buy Into Brazil Despite Huge Trade Deficit?
Louie Grint, The Motley Fool - Motley Fool - Wed Apr 09, 10:28AM CDT
Unfortunately, bad news is still coming from Latin America. Brazil, South America's largest economy, accumulated its worst foreign-trade deficit in 21 years. The deficit figure, which reached $6.1 billion for the first quarter, is almost 18% larger...

'Fast Money' Recap: S&P Snapback
at The Street - Wed Apr 09, 4:00AM CDT
The trading panel discussed whether investors can trust this latest rlly.

'Fast Money' Recap: The Profit-Taking Spreads
at The Street - Tue Apr 08, 4:00AM CDT
The trading panel discussed how investors are selling all sorts of sectors, including steel and home improvement.

iShares MSCI Brazil Index Fund Rises 2.69% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Apr 07, 3:46PM CDT
iShares MSCI Brazil Index Fund (NYSE:EWZ) traded in a range yesterday that spanned from a low of $46.44 to a high of $47.59. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $47.32 on volume of 29.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 2.69% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Apr 07, 3:46PM CDT
iShares MSCI Brazil Index Fund (NYSE:EWZ) traded in a range yesterday that spanned from a low of $46.44 to a high of $47.59. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $47.32 on volume of 29.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Is the Mexico ETF a Better Play on Latin America? - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Apr 07, 9:00AM CDT
If investors are looking for a Latin America ETF play, they may want to consider Mexico.

'Fast Money' Recap: More Market Downside Ahead?
at The Street - Sat Apr 05, 4:00AM CDT
The trading panel looked at the signs and wondered if the market is faking out investors.

11.3% Return Seen to Date on SmarTrend iShares MSCI Brazil Index Fund Call (EWZ)
Comtex SmarTrend(R) - Thu Apr 03, 9:32AM CDT
SmarTrend identified an Uptrend for iShares MSCI Brazil Index Fund (NYSE:EWZ) on February 27th, 2014 at $41.17. In approximately 1 month, iShares MSCI Brazil Index Fund has returned 11.33% as of today's recent price of $45.83.

Look for Shares of iShares MSCI Brazil Index Fund to Potentially Pullback after Yesterday's 2.41% Rise
Comtex SmarTrend(R) - Wed Apr 02, 3:42PM CDT
iShares MSCI Brazil Index Fund (NYSE:EWZ) traded in a range yesterday that spanned from a low of $45.01 to a high of $46.24. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $45.49 on volume of 18.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

SmarTrend Watching for Potential Pullback in Shares of iShares MSCI Brazil Index Fund After 2.41% Gain
Comtex SmarTrend(R) - Wed Apr 02, 3:41PM CDT
iShares MSCI Brazil Index Fund (NYSE:EWZ) traded in a range yesterday that spanned from a low of $45.01 to a high of $46.24. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $45.49 on volume of 18.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Will Election Hopes Boost The Fragile Five Emerging ETFs? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 9:00AM CDT
Many emerging market investments have been quite weak, can upcoming elections boost prices in key markets this year?

'Fast Money' Recap: Where to Start Taking Profits
at The Street - Tue Apr 01, 4:00AM CDT
The trading panel discussed the market rally and which stocks should be bought and sold now.

Will the Recent Surge in Brazilian ETFs Continue? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 9:00AM CDT
Brazil ETFs have been surging thanks to recent poll numbers. Can this move higher continue?

iShares MSCI Brazil Index Fund (EWZ) : Take profit @ $42.54
Trading Central - Tue Mar 25, 8:41AM CDT
The ETF is facing its declining 20-week moving average; we prefer to take profit right now and to close our long position opened on February 6th at last price ($42.54). Trading strategy: Close our long position at last price ($42.54).

'Fast Money' Recap: The Value of 'Old Tech' Stocks
at The Street - Tue Mar 25, 4:00AM CDT
The trading panel discussed why these stocks have solid upside momentum and reasonable valuations.

Look for Shares of iShares MSCI Brazil Index Fund to Potentially Pullback after Yesterday's 1.18% Rise
Comtex SmarTrend(R) - Mon Mar 24, 3:54PM CDT
iShares MSCI Brazil Index Fund (NYSE:EWZ) traded in a range yesterday that spanned from a low of $41.62 to a high of $42.38. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $42.17 on volume of 16.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 158

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 132

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 152

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 129

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 94

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
vVARDIS Debuts on NYSE: Transforming Dental Care

Updated Category News Views 92

A New Chapter for Dental Tech Mark your calendars, folks. vVARDIS is stepping onto the New York Stock Exchange (NYSE) stage, waving the banner of NYSE:VVVV. Now, if you've ever sat in that squeaky dental chair feeling the dread of a drill, vVARDIS might just be the new hero in town. Founded by the dynamic duo, Dr. Haley and Dr. Goly Abivardi, they're on a mission to...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 147

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading

Top 5 Most Recently Viewed Articles

Chris Larsen's Strategic XRP Moves: Implications for Investors

Updated Category News Views 333

Overview of Chris Larsen's Recent XRP Transactions Chris Larsen, the influential co-founder and executive chairman of Ripple, has been actively transferring substantial amounts of XRP. Recently, he moved approximately $26 million worth of XRP to Coinbase, one of the most prominent cryptocurrency exchanges. This transfer is part of a larger pattern, contributing to an...

Continue Reading
Mastercard's Options Activity Insights: Market Trends Explored

Updated Category News Views 143

Understanding Mastercard's Recent Options Activity Mastercard is currently in the spotlight as investors engage in noteworthy bearish actions. This indicates a prevailing sentiment among wealthy clients regarding their perspective on the financial giant. Investor Insights on Mastercard Our analysis indicates that certain trades of interest have emerged in the options...

Continue Reading
Discover How CryptoGO Revolutionizes Memecoin Trading

Updated Category News Views 222

Transforming Memecoin Trading for Beginners CryptoGO is a innovative Telegram mini-app crafted specifically to ease the entry of newcomers into the world of memecoin trading. By harnessing the power of the Solana blockchain, CryptoGO revolutionizes how users engage with meme tokens, making the process both accessible and enjoyable. With support for fiat currency, users...

Continue Reading
Pyxis Oncology Updates on Financial Status and Future Plans

Updated Category News Views 325

Latest Developments at Pyxis Oncology Pyxis Oncology, Inc. has recently made headlines with its remarkable progress in the field of oncology. The development and ongoing trials of their innovative therapy, micvotabart pelidotin (MICVO), have shown encouraging preclinical results, highlighting its unique three-pronged mechanism of action. This mechanism enhances anti-tumor...

Continue Reading
Florida’s Cannabis Legalization Gains Momentum with Herald Support

Updated Category News Views 93

Support for Cannabis Legalization Gains Traction The Miami Herald, a notable publication in Florida with a rich history dating back to 1903, has come out strongly in favor of the state's cannabis legalization initiative known as Amendment 3. The proposal will be presented to voters in the upcoming election, marking a significant shift in public policy towards cannabis....

Continue Reading